+
Help Us Enhance Your NephU Experience

Help Us Enhance Your NephU Experience

User experience form

What are your goals for visiting NephU?(Required)
How would you like to hear from us?(Required)
Agree(Required)
This field is for validation purposes and should be left unchanged.

Archives

Loading Events

Major Depressive Disorder In Chronic Kidney Disease

A joint virtual live event for NephU & PsychU members.

In this virtual live event, Alf Carroll, MS, PA-C, and Alyssa Peckham, PharmD, BCPP discuss the high prevalence of major depressive disorder (MDD) among patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD).

Major depressive disorder affects more than 260 million people worldwide.1 The reported prevalence of depression in patients with chronic kidney disease ranges from 20-65%.2 This webinar provides an overview of both MDD and CKD and discusses their overlap of symptomology.

1World Health Organization. Fact Sheet on Depression. (2012) https://www.who.int/health-topics/depression#tab=tab_1
2Teles F et al. Clinics (Sao Paulo). 2014 ;69(3):198-202.

Alf Carroll and Dr Alyssa Peckham are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).

You must be logged in to register for this event. Please Log In or Join Now
Featured Speakers
Alf Carroll

Alf Carroll, MS, PA-C

Nephrology Senior Medical Science Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Alf Carroll, MS, PA-C is a Medical Science Liaison at Otsuka Pharmaceutical Development and Commercialization. He earned his Bachelor of Science in Biology and Master of Science in Physician Assistant Studies from Northeastern University in Boston, Massachusetts. He worked clinically as a Physician Assistant in the Emergency Department at Massachusetts General Hospital and South Shore Hospital in the Boston area. Prior to joining Otsuka, Alf held a position at AstraZeneca Pharmaceuticals on their Market Access team focusing on large health systems in New England, covering the cardiovascular, renal, endocrine, and respiratory therapeutic areas.

Alyssa Peckham

Alyssa Peckham, PharmD, BCPP

Medical Science Liaison, Neuroscience
    Otsuka Pharmaceutical Development & Commercialization, Inc.*

Areas of Expertise:

  • Addiction Medicine
  • Mood Disorders
  • Anxiety
  • Schizophrenia
  • Psychopharmacology
  • Public Health
Location

Online

Join Today for Instant Access to all NephU Offerings.

Membership is free!

Join NephU today at no cost to register for this event and access to other premium content.

  • The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
  • Quickly learn more about the topics that interest you.
  • Access our library of on-demand kidney health resources
  • Gain key insights from industry experts & though leaders.